Who are IVF-M HP Inj.'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Follitrope PFS.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ivf-m-hp-inj.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

IVF-M HP Inj. — Competitive Intelligence Brief

IVF-M HP Inj. (IVF-M HP Inj.) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotropin (recombinant FSH). Area: Reproductive Medicine / Fertility.

marketed Gonadotropin (recombinant FSH) FSH receptor (FSHR) Reproductive Medicine / Fertility Small molecule Live · refreshed every 30 min

Target snapshot

IVF-M HP Inj. (IVF-M HP Inj.) — LG Life Sciences. IVF-M HP is a recombinant human follicle-stimulating hormone (FSH) that stimulates ovarian follicle development and estrogen production in women undergoing assisted reproductive therapy.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
IVF-M HP Inj. TARGET	IVF-M HP Inj.	LG Life Sciences	marketed	Gonadotropin (recombinant FSH)	FSH receptor (FSHR)
Follitrope PFS	Follitrope PFS	Hangzhou YuYuan Bioscience Technology Co., Ltd.	phase 3	Gonadotropin (recombinant FSH)	FSH receptor (FSHR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gonadotropin (recombinant FSH) class)

Hangzhou YuYuan Bioscience Technology Co., Ltd. · 1 drug in this class
LG Life Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). IVF-M HP Inj. — Competitive Intelligence Brief. https://druglandscape.com/ci/ivf-m-hp-inj. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab